Autonomous Healthcare Inc.

Santa Clara, CA

UEI
MTDYDS8M2176
CAGE
6GSL2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3080 Olcott St c210, Santa Clara, CA 95054, USA
Founded
2013
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Autonomous Healthcare Inc., based in Santa Clara, California, is a for-profit medical device and healthcare technology innovator that operates exclusively as a federal grant recipient, developing clinical decision support systems and non-contact patient monitoring technologies for the National Institutes of Health, the National Science Foundation, and the Department of Defense. The vendor holds no federal contracts; all recent federal activity is grant-funded research and development work.

Autonomous Healthcare's capability portfolio centers on bedside clinical decision support systems and non-contact remote monitoring for critical care settings. The company's two active grant programs address high-acuity clinical challenges: E-Fusion, a Phase I SBIR award from the National Heart, Lung, and Blood Institute (NHLBI) for $305,999 (September 2026 through August 2027), develops a clinical decision support system to assist anesthesiologists, anesthetists, and critical care nurses with vasopressor titration and blood pressure management during surgery and in intensive care units by monitoring mean arterial pressure and recommending infusion rate adjustments. In parallel, Autonomous Healthcare holds two NIDA grants for non-contact monitoring of opioid-induced respiratory depression: a Phase II effort awarded June 2023 with ultimate completion July 2028, and an earlier Phase I award (June 2023, completed May 2025) developing Doppler radar and depth-imaging sensor systems to detect respiratory depression in hospital wards, home settings, and supervised consumption spaces without physical contact.

Customer concentration is dispersed across the federal research ecosystem. The top five grantor agencies account for 78% of award count: the National Institute on Drug Abuse leads with five awards, followed by the National Science Foundation (three awards), NHLBI (two awards), NASA Shared Services Center ($874 thousand combined potential value), and the Army Medical Command ($300 thousand). The vendor's combined potential value across all eighteen awards totals $1.9 million, though cumulative obligated dollars of $12.9 million indicate substantial phase completions and ongoing performance. Three awards face ultimate completion within the next twenty-four months. All work is performed in Santa Clara, California, with no subcontracting footprint in the source data.

Quick answers

Is Autonomous Healthcare Inc. registered in SAM.gov?

Yes. Autonomous Healthcare Inc.'s SAM.gov registration is active through April 9, 2027.

What is Autonomous Healthcare Inc.'s most recent federal award?

Autonomous Healthcare Inc.'s most recent federal grant award is A feasibility study for a clinical decision support system to assist with vasopressor titration - blood pressure… (R43HL187059), from National Heart Lung and Blood Institute (NIH), on September 1, 2026.

On GovTribe

See Autonomous Healthcare Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors